Showing results (271-280 of 39,526) with videos related to
Sort By:
Pageof 3,953
Blood|January 14, 2025
Novel mechanisms of resistance in CLL: variant BTK mutations in second-generation and noncovalent BTK inhibitorsConstantine S Tam, Shalini Balendran, Piers BlomberyBlood|December 9, 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivationViral Shah, George Giotopoulos, Hikari Osaki, et al.Blood|December 9, 2024
The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myelomaMun Yee Koh, Tae-Hoon Chung, Nicole Xin Ning Tang, et al.Blood|December 9, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromesJacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.Blood|December 9, 2024
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUSOla Landgren, Ajai Chari, Yael C Cohen, et al.Blood|December 4, 2024
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myelomaDan T Vogl, Shebli Atrash, Sarah A Holstein, et al.Blood|December 2, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphomaHun Ju Lee, Rod Ramchandren, Judah Friedman, et al.Blood|December 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVHAustin Kulasekararaj, Morag Griffin, Caroline Piatek, et al.Blood|December 10, 2024
Inflammation-driven NF-κB signaling represses ferroportin transcription in macrophages via HDAC1 and HDAC3Oriana Marques, Natalie K Horvat, Laura Zechner, et al.Pageof 3,953